Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × osimertinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 14 Lung Neoplasms 8 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Stage II-IIIB Non-small Cell Lung Carcinoma 1 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Cisplatin 4 Platinum 3 Pemetrexed 3 1,2-diaminocyclohexaneplatinum II citrate 3 pembrolizumab 2 tremelimumab 1 methoxyamine 1 decitabine and cedazuridine drug combination 1 cediranib 1 atezolizumab 1 aldesleukin 1 Radiotherapy 1 Radiation 1 Pharmaceutical Preparations 1 Nivolumab 1 Ipilimumab 1 Interleukin-2 1 Imprint II 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1 Cyclophosphamide 1 Carboplatin 1 Bevacizumab 1 BAY 1895344 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡